Add to ORKGThe aim of the present study was to evaluate the effect of a single haemodialysis (HD) session on serum fetuin-A levels, considered a negative acute phase response marker; moreover, we evaluated the behaviour of fibrinogen and high sensitivity C-reactive protein (hsCRP) as acute phase response and chronic/subclinical inflammation markers, respectively, after a single HD session. Serum fetuin-A, albumin, hsCRP and fibrinogen were measured in 72 patients before and after a single HD session. After a single HD session, we observed a significant increase in fibrinogen levels, while fetuin-A levels decreased (p<0.05). Also, hsCRP levels were significantly increased. The significant decrease of fetuin-A levels after a single HD session is consist...
Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stre...
End-stage renal failure (ESRF) is associated with a higher risk of cardiovascular disease (CVD) than...
Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors and...
The aim of the present study was to evaluate the effect of a single haemodialysis (HD) session on se...
The atherosclerotic Cardiovascular Disease (CVD) is frequently observed in End-Stage Renal Disease (...
Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage r...
Background: Inflammation is associated with enhanced cardiovascular risk profile and increased cardi...
Fetuin-A is a calcification inhibitor, negative acute phase response marker and cardiovascular morta...
Background: Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD). An ...
Background: In end-stage renal disease, fetuin-A has been demonstrated to be reduced and inversely r...
Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen l...
Inflammatory signals associated with hemodialysis.BackgroundInflammation is highly prevalent in chro...
Abstract. End-stage renal failure (ESRF) is associated with a higher risk of cardiovascular disease ...
Several studies showed that Fetuin-a is an extracellular calcium-regulatory protein acting as a pote...
Fetuin-A, a hepatic glycoprotein present in the circulation, is a potential inhibitor for systemic c...
Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stre...
End-stage renal failure (ESRF) is associated with a higher risk of cardiovascular disease (CVD) than...
Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors and...
The aim of the present study was to evaluate the effect of a single haemodialysis (HD) session on se...
The atherosclerotic Cardiovascular Disease (CVD) is frequently observed in End-Stage Renal Disease (...
Background: Cardiovascular disease (CVD) is a common cause of morbidity and mortality in end-stage r...
Background: Inflammation is associated with enhanced cardiovascular risk profile and increased cardi...
Fetuin-A is a calcification inhibitor, negative acute phase response marker and cardiovascular morta...
Background: Cardiovascular disease (CVD) is the leading cause of mortality in hemodialysis (HD). An ...
Background: In end-stage renal disease, fetuin-A has been demonstrated to be reduced and inversely r...
Impact of albumin synthesis rate and the acute phase response in the dual regulation of fibrinogen l...
Inflammatory signals associated with hemodialysis.BackgroundInflammation is highly prevalent in chro...
Abstract. End-stage renal failure (ESRF) is associated with a higher risk of cardiovascular disease ...
Several studies showed that Fetuin-a is an extracellular calcium-regulatory protein acting as a pote...
Fetuin-A, a hepatic glycoprotein present in the circulation, is a potential inhibitor for systemic c...
Influence of initiation of maintenance hemodialysis on biomarkers of inflammation and oxidative stre...
End-stage renal failure (ESRF) is associated with a higher risk of cardiovascular disease (CVD) than...
Calcifying atherosclerosis is an active process, which is controlled by calcification inhibitors and...